Peter M. George

11.8k citations

272 papers · 7.0k indexed · 3 hit papers · h-index 42

Impact in

Nephrology top 1%
- Acute Kidney Injury Research
- Chronic Kidney Disease and Diabetes
Pulmonary and Respiratory Medicine top 1%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Blood properties and coagulation

Papers in

Pulmonary and Respiratory Medicine 99
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 47
- Blood properties and coagulation 27
- Chronic Obstructive Pulmonary Disease (COPD) Research 19
Clinical Biochemistry 19
- Metabolism and Genetic Disorders 19

Co-authors: Athol U. Wells Gísli Jenkins Michael Lever Stephen O. Brennan Christopher M Florkowski Stephen T. Chambers Russell Scott Sarah L. Molyneux
Journals: Annals of Clinical Biochemistry International Journal of Laboratory Medicine (14 papers)Clinical Biochemistry (10 papers)Thorax (8 papers)Clinical Chemistry (8 papers)Respirology (7 papers)
Partner nations: New Zealand United Kingdom Australia

In The Last Decade

Peter M. George

267 papers receiving 6.8k citations

Hit Papers

align trajectories log scale

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy 2020 · 774 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 The Lancet Respiratory Medicine
2020 The Lancet Respiratory Medicine
2019 The Lancet Respiratory Medicine

Peers

Countries citing papers authored by Peter M. George

Since Specialization

Citations

This map shows the geographic impact of Peter M. George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. George more than expected).

Fields of papers citing papers by Peter M. George

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. George. The network helps show where Peter M. George may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter M. George, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter M. George Line = papers co-authored together Peter M. George links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Survival in Patients With Pulmonary Hypertension Associated With Fibrotic Interstitial Lung Disease is Independent of ILD Subtype: A London Study American Journal of Respiratory and Critical Care Medicine ·Laura Price, Ifan Jenkin, Konstantinos Dimopoulos, E. Iwinski, Timothy J. W. Dawes, Satya Rizky Suhermanto, Colm McCabe, Darko Panov, Vasileios Kouranos, Adrian Wells, 王鸿波, Philip L. Molyneaux, Peter M. George, SJ Wort	2025	0
2	Identification of progressive pulmonary fibrosis: consensus findings from a modified Delphi study Respiratory Research ·Athol U. Wells, Simon Walsh, Ayodeji Adegunsoye, Vincent Cottin, Sonye K. Danoff, Anand Devaraj, Kevin R. Flaherty, Peter M. George, Kerri A. Johannson, Martin Kolb, Yasuhiro Kondoh, Andrew G. Nicholson, Sara Tomassetti, Elizabeth R. Volkmann, Kevin K. Brown	2024	3
3	The impact of hiatus hernia in hypersensitivity pneumonitis Respirology ·José Fer- Reira, Carmel Stock, Paula Macarena Libuy Pulgar, Gísli Jenkins, Felix Chua, Philip L. Molyneaux, Anand Devaraj, Vasileios Kouranos, Athol U. Wells, Elisabetta Renzoni, Simon Padley, Sujal R. Desai, Peter M. George	2024	0
4	Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study Thorax ·Ю. Ю. Герасименко, Ann Morgan, Peter M. George, Jennifer K Quint	2024	14
5	Deep-learning CT imaging algorithm to detect usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease: association with disease progression and survival Lara D. Veeken ·Carmel Stock, Nan Yang, Yingying Fang, Maria Kokosi, Vasileios Kouranos, Peter M. George, Felix Chua, Gísli Jenkins, Anand Devaraj, Sujal R. Desai, Christopher P. Denton, Athol U. Wells, Simon Walsh, Elisabetta Renzoni	2024	3
6	Serum C‐reactive protein is associated with earlier mortality across different interstitial lung diseases Respirology ·Carmel Stock, 김창남, Vasileios Kouranos, Joseph Jacob, Maria Kokosi, Peter M. George, Felix Chua, Athol U. Wells, Piersante Sestini, Elisabetta Renzoni	2023	13
7	Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review BMJ Open Respiratory Research ·Ю. Ю. Герасименко, TONY POMBO, Ann Morgan, Peter M. George, Jennifer K Quint	2023	53
8	Change in gait speed and adverse outcomes in patients with idiopathic pulmonary fibrosis: A prospective cohort study Respirology ·Claire M. Nolan, Susie Schofield, Matthew Maddocks, Suhani Patel, Ruth E Barker, Jessica A. Walsh, Abdulgader Khaled Basamad, Peter M. George, Philip L. Molyneaux, Toby M. Maher, Paul Cullinan, William D‐C Man	2023	3
9	Short‐term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis Respirology ·Claudio Macaluso, Cristina Boccabella, Maria Kokosi, Wangjian Zhou, Vasileios Kouranos, Peter M. George, George Margaritopoulos, Philip L. Molyneaux, Felix Chua, Toby M. Maher, Gísli Jenkins, Andrew G. Nicholson, Sujal R. Desai, Anand Devaraj, Athol U. Wells, Elisabetta Renzoni, Carmel Stock	2022	12
10	Implementation and evaluation of a rural general practice assessment pathway for possible cardiac chest pain using point-of-care troponin testing: a pilot study BMJ Open ·Marco Grzegorczyk, Joanna M. Young, DU Hui-xia, Mandapati Rohith Kumar, John W. Pickering, Stephen Du Toit, Raymond A Zink, T. Uchida, Chris Frampton, Gerard Devlin, Peter M. George, Martin Than	2022	6
11	Muscle stimulation in advanced idiopathic pulmonary fibrosis: a randomised placebo-controlled feasibility study BMJ Open ·Claire M. Nolan, Suhani Patel, Ruth E Barker, Jessica A. Walsh, Abdulgader Khaled Basamad, Matthew Maddocks, Peter M. George, Elisabetta Renzoni, Athol U. Wells, Philip L. Molyneaux, Vasileios Kouranos, Felix Chua, Toby M. Maher, William D‐C Man	2021	10
12	Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression Respirology ·Carmel Stock, Rachel K. Hoyles, Cécile Daccord, Maria Kokosi, Dina Visca, Angelo De Lauretis, Veronica Alfieri, Vasileios Kouranos, George Margaritopoulos, Peter M. George, Philip L. Molyneaux, Felix Chua, Toby M. Maher, David Abraham, Voon H Ong, Jackie Donovan, Piersante Sestini, Christopher P. Denton, Athol U. Wells, Elisabetta Renzoni	2020	35
13	Idiopathic pulmonary fibrosis: airway volume measurement identifies progressive disease on computed tomography scans ERJ Open Research ·T. M. McLellan, Peter M. George, Paul Ford, Jan De Backer, Cedric Van Holsbeke, H. Schwentek, Nicholas Screaton, Alessandro Ruggiero, Muhunthan Thillai	2020	8
14	Interaction between the promoterMUC5Bpolymorphism and mucin expression: is there a difference according to ILD subtype? Thorax ·Carmel Stock, Caterina Conti, Tatyana Pavlovna, Gaetano Caramori, Philip L. Molyneaux, Peter M. George, Maria Kokosi, Ieva Vēvere, Toby M. Maher, Felix Chua, Alexandra Rice, Christopher P. Denton, Andrew G. Nicholson, Athol U. Wells, Piersante Sestini, Elisabetta Renzoni	2020	8
15	Pulmonary hypertension in interstitial lung disease: Limitations of echocardiography compared to cardiac catheterization Respirology ·Gregory J. Keir, Stephen J. Wort, Maria Kokosi, Peter M. George, Simon Walsh, Joseph Jacob, Laura Price, Simon Bax, Elisabetta Renzoni, Toby M. Maher, Peter S. Macdonald, David M. Hansell, Athol U. Wells	2018	45
16	Using the experiences of people with familial hypercholesterolaemia to help reduce the risk of cardiovascular disease: a qualitative systematic review Journal of Advanced Nursing ·北京市水产试验站品种组, Peter M. George, Lisa Whitehead	2012	15
17	Endothelin‐1 as a Mediator and Potential Biomarker for Interferon Induced Pulmonary Toxicity Pulmonary Circulation ·Peter M. George, Morven Cunningham, Lea Niwar, Rekha Badiger, William Alazawi, Graham R. Foster, Jane A. Mitchell	2012	18
18	Spectrum of MECP2 mutations in New Zealand Rett syndrome patients. PubMed ·Anthony Raizis, Кинцанс Владимир, Richard Mackay, Peter M. George	2009	5
19	Abstract 343: Coenzyme Q10 does not Improve Simvastatin Tolerability in Dyslipidemic Patients with Prior Statin-Induced Myalgia Circulation ·Joanna M. Young, Christopher M Florkowski, Sarah L. Molyneux, 문광헌, Christopher Frampton, Peter M. George, Russell Scott	2006	4
20	The significance of haemochromatosis gene mutations in the general population: implications for screening Gut ·Michael J. Burt, Peter M. George, Valery Vinogradov, Judith A Collett, Chris Frampton, Timothy M. Chapman, T A Walmsley, B. A. Chapman	1998	186

About Peter M. George

Peter M. George is a scholar working on Pulmonary and Respiratory Medicine, Clinical Biochemistry, Hematology, Rheumatology and Nephrology, having authored 272 papers that have together received 7.0k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (47 papers), Folate and B Vitamins Research (28 papers), Blood properties and coagulation (27 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (19 papers), Metabolism and Genetic Disorders (19 papers), Acute Myocardial Infarction Research (13 papers), Lipoproteins and Cardiovascular Health (12 papers) and Sarcoidosis and Beryllium Toxicity Research (11 papers). The work is most often cited by research in Nephrology (589 citations), Pulmonary and Respiratory Medicine (2.1k citations), Hematology (604 citations), Critical Care and Intensive Care Medicine (254 citations) and Clinical Biochemistry (270 citations). Peter M. George has collaborated with scholars based in New Zealand, United Kingdom and Australia. Frequent co-authors include Athol U. Wells, Gísli Jenkins, Michael Lever, Stephen O. Brennan, Christopher M Florkowski, Stephen T. Chambers, Russell Scott, Sarah L. Molyneux, Christopher Frampton and Joanna M. Young. Their work appears in journals such as Annals of Clinical Biochemistry International Journal of Laboratory Medicine, Clinical Biochemistry, Thorax, Clinical Chemistry and Respirology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact